TABLE 3.
Estimated relative increase in positivity (%) of NAAT performed at cervix or urine site over PACE2 performed at cervix
| Characteristic | % Increase in positivitya
|
|||
|---|---|---|---|---|
| Cervical tests
|
Urine tests
|
|||
| LCR | PCR | LCR | PCR | |
| Age (yr) | ||||
| <20 | 38 | 19 | 22 | 16 |
| ≥20 | 45 | 31 | 44 | 33 |
| Mucopurulent endocervical discharge | ||||
| Present | 35 | 28 | 34 | 22 |
| Absent | 46 | 28 | 39 | 30 |
| Current menses | ||||
| Present | 51 | 31 | 20 | 14 |
| Absent | 41 | 26 | 37 | 27 |
| Cervical culture positive for N. gonorrhoeae | ||||
| Present | 45 | 26 | 25 | 19 |
| Absent | 42 | 27 | 44 | 31 |
| Dysuria | ||||
| Present | 50 | 6 | 73 | 46 |
| Absent | 41 | 27 | 35 | 26 |
| Hematuriab | ||||
| Present | 32 | 21 | 29 | 21 |
| Absent | 51 | 34 | 45 | 32 |
| Urine leukocyte esterase result | ||||
| Positive | 35 | 24 | 37 | 30 |
| Negative | 46 | 21 | 37 | 14 |
Adjusted for variation in test performance across centers.
Defined as presence of blood on urine dipstick test.